ELMMB logo
Facebook logo Twitter logo
Menu
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 
 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer
 

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

 TitleCreatedDownload
application/pdfMexilitenene_Class_1-Recall-2022-007.pdf (216KB)04/08/2022Download
 Information for HCP - ACTION NOW 
application/pdfParoxetine 40mf fc tablets_crescent pharmac_ cl 2meds recall_270422.pdf (97KB)27/04/2022Download
  
application/pdfBeclometasone dip nasal spray Class 4 meds defect EL__22_A_14_Final150322.pdf (213KB)15/03/2022Download
 Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. See Appendix 1 in this notification for detailed Braille information 
application/pdfEfudix 5% cream Class 2 meds recall_MHRA_EL__22_A_07_170222.pdf (113KB)17/02/2022Download
 Uni Health Distribution is aware of a potential issue where the leaflet contained within Efudix 5% w/w cream (2 x 20g) pack, batch 80193439/B may be incorrect. The issue was identified due to a... 
application/pdfMydrilate 0.5% Class 2 meds recall 081221.pdf (91KB)08/12/2021Download
 Intrapharm Laboratories Ltd are recalling the above batch of Mydrilate 0.5 % Eye Drops 5ml as a precautionary measure due to out of specification results for related substances obtained during... 
application/pdfMometasone furoate 50mcg nasal_ Cl4 meds recall_112021.pdf (98KB)29/11/2021Download
 PilsCo Ltd. have identified a error relating to the wording on the outer carton label. The label affixed on the bottle states: 'use within 2 weeks of first use', instead of the correct label... 
application/pdfDiuril oral soln_unlicensed_ Cl4 meds recall_112021_Final.pdf (86KB)29/11/2021Download
 Mawdsley-Brooks & Company Limited would like to notify you of an error with the patient information leaflet (PIL) that has been provided with the above batches of products. The PIL provided was a... 
application/pdfMethadone_Physeptone 5mg tabs Cl 3 meds recall_martindale pharm 221121.pdf (108KB)22/11/2021Download
 Martindale Pharma is recalling the above batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small number of blister pockets. Advice for... 
application/pdfIkervis1mg_1ml & Verkazia 1mg_1ml eye drps class 2 meds recall_MHRA_181121.pdf (142KB)18/11/2021Download
 SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active pharmaceutical ingredient ... 
application/pdfCold and Flu Relief Capsules_various liveriesEL_Final 111121.pdf (225KB)11/11/2021Download
 Perrigo are recalling the above batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products as noted above. The leaflet and carton... 
application/pdfBimatoprost Aspire 0.3mg per ml eye drops Class 3 meds recall 261021.pdf (112KB)26/10/2021Download
 Aspire Pharma Limited is recalling the above batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure due to the identification of... 
application/pdfChampix_Pfizer_all strengths_ class2 medicines recall_oct 21.pdf (143KB)15/10/2021Download
  They are being updated on a regular basis so please make sure to check you have the latest version. 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]
[ Next » ]